Different bone sesitivity to malformations induced by procarbazine in fetal rats.
The study aimed at to induce cleft-lip-alveolus-palate (CLAP) applying procarbazine in rat fetuses at the 14(th) day of pregnancy, to supply thiocyanate and/or folic acid sufficient for preventive treatment and subsequently to investigate cleft extent in the palatal area as well as bone maturity. In this animal model, female primiparous inbred rats (LEW.1A) were used. The gravid animals were separated into treatment groups: group K (control), group P (procarbazine), group TP (thiocyanate and procarbazine) and group FTP (folic acid, thiocyanate, procarbazine). The results reveal that procarbazine may induce clefts in the palate area. Clefts occurred most frequently in group TP and mainly comprised subtotal clefts of the posterior secondary palate. As for palatal length, group FTP displayed the longest palate which was significantly different only from group K. A different picture was shown for the secondary palate with group TP displaying the shortest values which were significantly different from those in groups K, P, and FTP. Thus, group TP showed the most marked negative changes both for cleft frequency and palatal length as compared to group K and the other groups. The preventive application of either thiocyanate (TP) or thiocaynate and folic acid combined (group FTP) failed to completely prevent cleft formation in the palate area. In conclusion, a preventive effect on palatal clefts and growth inhibition could not be proved for the vitaminoid thiocyanate.
Weingartner
J
J
Institute for Anatomy and Cell Biology, University of Greifswald, Germany. weingaer@uni-greifswald.de
Proff
P
P
Fanghanel
J
J
Kundt
G
G
Gedrange
T
T
Kubein-Meesenburg
D
D
Gredes
T
T
D000014:Abnormalities, Drug-Induced / Q000196:embryology / Q000209:etiology / Q000517:prevention & control; D000818:Animals; D001842:Bone and Bones / Q000187:drug effects* / Q000196:embryology; D002972:Cleft Palate / Q000139:chemically induced / Q000196:embryology / Q000517:prevention & control; D004359:Drug Therapy, Combination; D005260:Female; D047109:Fetal Development / Q000187:drug effects*; D005492:Folic Acid / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D005865:Gestational Age; D011247:Pregnancy; D011344:Procarbazine / Q000633:toxicity*; D051381:Rats; D011917:Rats, Inbred Lew; D013861:Thiocyanates / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use
D013861:Thiocyanates; D011344:Procarbazine; D005492:Folic Acid; C031760:thiocyanate